🕒 Friday 14 February 2025 Fri, 14 Feb 2025

AMP reported a robust FY24 with underlying NPAT rising 15.1% to $236 million, driven by disciplined cost management and strong cash flows. The company declared a final dividend of 1.0 cents per share and is set to launch a new digital bank in February 2025, signaling strategic growth in wealth and banking sectors.

AMP Limited has announced a modest dividend of AUD 0.01 per share for the six months ending December 2024, with 20% franked and 80% unfranked components, signaling steady shareholder returns amid evolving market conditions.

AMP Limited’s 2024 results reveal a 43% drop in statutory net profit to $150 million, offset by a 15.1% rise in underlying profit to $236 million, alongside the completion of its Advice business sale and the launch of a new digital bank.

GQG Partners delivered robust full-year 2024 results, marked by a 26.9% increase in funds under management and nearly 47% growth in net revenue, underpinned by strong investment performance and strategic initiatives including Private Capital Solutions and a new Abu Dhabi office.

GQG Partners reported a stellar 2024 with net inflows doubling to US$20.2 billion and funds under management climbing nearly 27%, underpinning strong revenue and earnings growth. The firm also expanded its dividend payout range, signaling confidence in future capital management.

GQG Partners Inc. has announced a quarterly ordinary dividend of USD 0.0378 per CDI, payable on March 27, 2025, with an option for Australian dollar conversion at a specified exchange rate.

GQG Partners Inc. reported strong financial results for 2024, with significant increases in revenue, net income, and funds under management, alongside a raised dividend and strategic moves including the deconsolidation of its PCS Master Fund.

AVITA Medical reported a strong 30% increase in Q4 2024 commercial revenue and amended its credit agreement with OrbiMed to adjust revenue covenants through 2026. The company is poised for significant growth with new product rollouts and expects profitability by year-end 2025.

AVITA Medical's Q4 2024 earnings reveal strong commercial growth alongside the launch of Cohealyx, a novel collagen-based skin substitute that promises to transform acute wound care.

AVITA Medical reported a robust 30% increase in Q4 2024 commercial revenue alongside key FDA clearances, setting the stage for ambitious growth in 2025.

Everest Metals Corporation has successfully extracted its first gold from the bulk sampling program at the Revere Gold Project, producing approximately 1.4 tonnes of concentrate and advancing towards a maiden JORC resource estimate.

BPM Minerals has commenced a significant 6,000m aircore drilling program at its Claw Gold Project in Western Australia, aiming to extend known gold mineralisation along an 8km corridor adjacent to Capricorn Metals' Mount Gibson Gold Project.

Hamelin Gold has identified a significant 500-metre gold anomaly at its Ularring Gold Project using advanced soil sampling technology, setting the stage for a targeted drilling campaign starting in March 2025.

Olympio Metals has entered an Option Agreement to sell its remaining Halls Creek tenements to Clutch Group, enabling a sharper focus on its flagship Dufay Cu-Au Project in Quebec.

Ragnar Metals has identified multiple large conductive anomalies at its Viken Project in Sweden, reinforcing the potential for significant uranium, vanadium, and molybdenum mineralisation. These findings, derived from reprocessed VLF geophysics and historical drilling data, set the stage for targeted exploration.

Civmec’s 1H FY25 results reveal robust revenue growth and a strong balance sheet, underpinned by a diversified project pipeline and strategic moves into naval shipbuilding and material handling equipment manufacturing.

Civmec Limited reports solid first-half FY25 results with revenue growth and a stable dividend, while navigating margin pressures and advancing strategic projects.

Sipa Resources has completed the acquisition of four advanced gold exploration projects across South Australia and Western Australia, backed by a $1.75 million capital raise and the strategic appointment of industry veteran Stephen Biggins to its board.

Meridian Energy's January 2025 report reveals a sharp drop in national hydro storage and inflows, coinciding with one of the driest Januarys on record and a notable dip in retail sales volumes.

Cochlear Limited posted a 6% increase in HY25 sales revenue driven by strong implant sales but anticipates FY25 profits at the lower end of guidance due to declining services revenue and rising cloud investments.

HealthCo Healthcare & Wellness REIT reported a solid 5% increase in Funds From Operations (FFO) and Distribution Per Unit (DPU) for the first half of FY25, underpinned by stable asset valuations and a robust healthcare portfolio.

Cochlear Limited posted a 5% increase in sales revenue to $1.17 billion for the half year ended December 2024, driven by strong cochlear and acoustic implant growth despite a decline in Services revenue. The company anticipates FY25 underlying net profit at the lower end of guidance amid increased cloud investments and prepares for new product launches.

HealthCo Healthcare & Wellness REIT reports solid 5% growth in FFO and DPU for 1H FY25, maintaining strong occupancy and gearing levels despite ongoing Healthscope lease speculation.

Cochlear Limited has announced a fully franked dividend of AUD 2.15 per share for the six months ending December 2024, payable in multiple currencies on April 14, 2025.